December 2003

Patent It in Canada logo in a gray background | Patent It in Canada
Intellectual Property
Patent It in CanadaPatent It in Canada
Patent It in Canada
Dec 1, 2003
byBPI Contributor
Indian Biotech on the Rise logo in a gray background | Indian Biotech on the Rise
Bioregions
Indian Biotech on the RiseIndian Biotech on the Rise
Indian Biotech on the Rise
Dec 1, 2003
byBPI Contributor
NS0 Serum-Free Culture and Applications logo in a gray background | NS0 Serum-Free Culture and Applications
Cell Culture Media
NS0 Serum-Free Culture and ApplicationsNS0 Serum-Free Culture and Applications
NS0 Serum-Free Culture and Applications
Dec 1, 2003
byBPI Contributor
Changes in US Immigration Law logo in a gray background | Changes in US Immigration Law
Business
Changes in US Immigration LawChanges in US Immigration Law
Changes in US Immigration Law
Dec 1, 2003
byBPI Contributor
Case Studies in Contract Biomanufacturing logo in a gray background | Case Studies in Contract Biomanufacturing
Contract Services
Case Studies in Contract BiomanufacturingCase Studies in Contract Biomanufacturing
Case Studies in Contract Biomanufacturing
Dec 1, 2003
byBPI Contributor
Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature December 2003Products, Services, and Literature December 2003
Products, Services, and Literature
Dec 1, 2003
byBPI Contributor
Stimulating Extracellular Matrix Production By Inter vertebral Disc Cells logo in a gray background | Stimulating Extracellular Matrix Production By Inter vertebral Disc Cells
Cell Therapies
Stimulating Extracellular Matrix Production By Inter vertebral Disc CellsStimulating Extracellular Matrix Production By Inter vertebral Disc Cells
Stimulating Extracellular Matrix Production By Inter vertebral Disc Cells
Dec 1, 2003
byBPI Contributor
A Useful Resource logo in a gray background | A Useful Resource
Business
A Useful ResourceA Useful Resource
A Useful Resource
Dec 1, 2003
byBPI Contributor
Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor logo in a gray background | Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor
MAb
Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank BioreactorProducing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor
Producing an Anti-β2 Integrin MAb By a Hybridoma Cell Line in a 2-Liter Stirred-Tank Bioreactor
Dec 1, 2003
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024